当前位置：
X-MOL 学术
›
Ann. Hematol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy.
Annals of Hematology ( IF 3.0 ) Pub Date : 2019-09-19 , DOI: 10.1007/s00277-019-03802-y Mario Tiribelli 1 , Elisabetta Abruzzese 2 , Isabella Capodanno 3 , Federica Sorà 4 , Elena Trabacchi 5 , Alessandra Iurlo 6 , Luigiana Luciano 7 , Gianni Binotto 8 , Massimiliano Bonifacio 9 , Mario Annunziata 10 , Monica Crugnola 11 , Renato Fanin 1
中文翻译：
博舒替尼在达沙替尼治疗下发展为胸腔积液的慢性CML患者中的疗效和安全性。
更新日期：2019-11-01
Annals of Hematology ( IF 3.0 ) Pub Date : 2019-09-19 , DOI: 10.1007/s00277-019-03802-y Mario Tiribelli 1 , Elisabetta Abruzzese 2 , Isabella Capodanno 3 , Federica Sorà 4 , Elena Trabacchi 5 , Alessandra Iurlo 6 , Luigiana Luciano 7 , Gianni Binotto 8 , Massimiliano Bonifacio 9 , Mario Annunziata 10 , Monica Crugnola 11 , Renato Fanin 1
Affiliation
中文翻译：
博舒替尼在达沙替尼治疗下发展为胸腔积液的慢性CML患者中的疗效和安全性。
京公网安备 11010802027423号